CN1509754A - Chinese medicine for treating hepatopathy - Google Patents
Chinese medicine for treating hepatopathy Download PDFInfo
- Publication number
- CN1509754A CN1509754A CNA021603367A CN02160336A CN1509754A CN 1509754 A CN1509754 A CN 1509754A CN A021603367 A CNA021603367 A CN A021603367A CN 02160336 A CN02160336 A CN 02160336A CN 1509754 A CN1509754 A CN 1509754A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- treatment
- fruit
- radix
- hepatopathy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating hepatitides A, B and C, hepatocirrhosis, hepatoascites and fatty liver is prepared from 14 Chinese-medicinal materials including astragalus root, Chinese angelica root, Chuan-xiong rhizome, wolfberry fruit, etc. Its advantages are high curative effect, no toxic by-effect and low cost.
Description
Technical field
The present invention relates to a kind of medicine, particularly relate to a kind of Chinese medicine for the treatment of hepatopathy.
Background technology
Hepatopathy is a kind of common disease, clinical common liver and bladder disease such as acute, chronic hepatitis, serious hepatitis, cirrhosis, liver cancer, hepatapostema, the infection of courage system, cholelithiasis etc., generally can range traditional Chinese medical science jaundice (dividing again yang jaundice, yin jaundice, acute febrile), hypochondriac pain, distension with, gather, the sick category such as liver obscess. Because hepatopathy is relatively more obstinate, the course of disease is very long, brings serious economic pressures and psychological burden for patient and family thereof. After the liberation, especially since the seventies, along with developing by leaps and bounds of China's medical and health cause, improving constantly of disease prevention and cure level, the liver and bladder disease preventing and controlling have obtained the great attention of governments at all levels and China's medical circle, thereby make the research of traditional Chinese medicine prevention liver and bladder disease obtain unprecedented progress and development. At present, human treatment for hepatopathy also is in the exploratory stage, and the medicine kind is a lot. Patent retrieval is found, someone has applied for the patent (96108400.6) of " oral liquid " by name, the oral liquid of comprising large acute diseases such as cholera and sunstroke medicine root in this all composition, carry on the back that forture paulownia root, polygoni cuspidati,radix, crow do not moor that root, Da Ye She Pao, serissa serissoide, kuh-seng, Canton love-pea vine, wood sunset, hypericum japonicum, Hedyotis diffusa Willd, the radix paeoniae rubrathe, the red sage root, bacterium are old in vain, fructus garedeniae, fructus toosendan, radix bupleuri, isatis root, Asiatic plantain being made. But this class medicine often exists soluble, poor stability, and absorbability is bad, the problems such as drug withdrawal " knock-on ".
Summary of the invention
The present invention mainly is that the solution prior art is existing soluble, poor stability, and absorbability is bad, the technical problem of drug withdrawal " knock-on " etc.
Above-mentioned technical problem of the present invention is mainly solved by following technical proposals: a kind of hepatic Chinese medicine, and it is made by components by weight mixture ratio:
The Radix Astragali 15~25g oriental wormwood 8~20g Radix Angelicae Sinensis 10~15g Radix Codonopsis 10~18g
Ligusticum wallichii 10~18g golden cypress 10~15g matrimony vine 5~10g fruit of Chinese magnoliavine 6~10g
The fruit of glossy privet 6~10g gekko 3~8g cassia bark 3~8g root of herbaceous peony 3~8g
Rhizoma cyperi 3~8g antelope's horn 1.5~4g
As preferably, the optimum ratio scheme of described component is:
The Radix Astragali 20~22g oriental wormwood 12~15g Radix Angelicae Sinensis 12~15g Radix Codonopsis 12~15g
Ligusticum wallichii 12~15g golden cypress 12~15g matrimony vine 6~8g fruit of Chinese magnoliavine 7~8g
The fruit of glossy privet 7~8g gekko 3~5g cassia bark 3~5g root of herbaceous peony 3~5g
Rhizoma cyperi 3~5g antelope's horn 2~2.5g
As preferably, described traditional Chinese medicinal components can also add the capsule of weeping forsythia 5~10g and Pogostemon cablin 5~10g.
As preferably, described traditional Chinese medicinal components can also add the dried rhizome of rehmannia 10~15g and donkey-hide gelatin 6~9g.
As preferably, described traditional Chinese medicinal components can also add RADIX ACONITILATERALIS PREPARATA 6~9g and dogwood fruit 6~9g.
Its manufacturing process of described traditional Chinese medicinal components is: be processed into pulvis behind the traditional Chinese medicine drying with above-mentioned prescription, become fine powder through regrind again, last honey is smelt ball.
Therefore, the present invention has following characteristics: wide adaptability can be used for the treatment of hepatitis A, hepatitis B, the third liver, cirrhosis, liver ascites, fatty liver etc.; Taking convenience, evident in efficacy, have no side effect, virus is discharged by urine, and is safe and reliable; The medicine source is extensive, gets it filled conveniently, and cost of manufacture is cheap. Take the medicine that the present invention makes, can strengthen autoimmunity, the kill virus cell reaches the equilibrium between yin and yang of human body, strengthens the body resistance to consolidate the constitution, to play the goal of the invention of supporting protecting liver.
The specific embodiment
Below by embodiment, technical scheme of the present invention is described in further detail.
Embodiment 1: a kind of Chinese medicine for the treatment of hepatopathy, and its prescription mix proportion scheme comprises, Radix Astragali 15g; Oriental wormwood 12g; Radix Angelicae Sinensis 12g; Radix Codonopsis 10g; Ligusticum wallichii 12g; Golden cypress 12g; Matrimony vine 6g; Fruit of Chinese magnoliavine 6g; Fruit of glossy privet 7g; Gekko 3g; Cassia bark 3g; Root of herbaceous peony 3g; Rhizoma cyperi 3g; Antelope's horn 1.5g. Be processed into pulvis behind the traditional Chinese medicine drying with above-mentioned prescription proportioning, become fine powder through regrind again, last honey is smelt ball.
Embodiment 2: a kind of Chinese medicine for the treatment of hepatopathy, and its prescription mix proportion scheme comprises, Radix Astragali 22g; Oriental wormwood 8g; Radix Angelicae Sinensis 15g; Radix Codonopsis 12g; Ligusticum wallichii 15g; Golden cypress 15g; Matrimony vine 8g; Fruit of Chinese magnoliavine 8g; Fruit of glossy privet 6g; Gekko 5g; Cassia bark 5g; Root of herbaceous peony 5g; Rhizoma cyperi 8g; Antelope's horn 2g; Capsule of weeping forsythia 10g; Pogostemon cablin 5g; Donkey-hide gelatin 9g. Preparation method is with embodiment 1.
Embodiment 3: a kind of Chinese medicine for the treatment of hepatopathy, and its prescription mix proportion scheme comprises, Radix Astragali 25g; Oriental wormwood 15g; Radix Angelicae Sinensis 13g; Radix Codonopsis 15g; Ligusticum wallichii 12g; Golden cypress 10g; Matrimony vine 5g; Fruit of Chinese magnoliavine 7g; Fruit of glossy privet 8g; Gekko 3g; Cassia bark 4g; Root of herbaceous peony 5g; Rhizoma cyperi 4g; Antelope's horn 1.5g; Dried rhizome of rehmannia 11g; RADIX ACONITILATERALIS PREPARATA 8g; Donkey-hide gelatin 7g. Preparation method is with embodiment 1.
Embodiment 4: a kind of Chinese medicine for the treatment of hepatopathy, and its prescription mix proportion scheme comprises, Radix Astragali 20g; Oriental wormwood 15g; Radix Angelicae Sinensis 10g; Radix Codonopsis 15g; Ligusticum wallichii 18g; Golden cypress 15g; Matrimony vine 8g; Fruit of Chinese magnoliavine 7g; Fruit of glossy privet 10g; Gekko 5g; Cassia bark 3g; Root of herbaceous peony 8g; Rhizoma cyperi 5g; Antelope's horn 2.5g; Pogostemon cablin 10g; Donkey-hide gelatin 6g; Dogwood fruit 9g. Preparation method is with embodiment 1.
Embodiment 5: a kind of Chinese medicine for the treatment of hepatopathy, and its prescription mix proportion scheme comprises, Radix Astragali 20g; Oriental wormwood 20g; Radix Angelicae Sinensis 15g; Radix Codonopsis 18g; Ligusticum wallichii 15g; Golden cypress 12g; Matrimony vine 10 g; Fruit of Chinese magnoliavine 10g; Fruit of glossy privet 8g; Gekko 8g; Cassia bark 5g; Root of herbaceous peony 5g; Rhizoma cyperi 5g; Antelope's horn 2g; Pogostemon cablin 5g; Donkey-hide gelatin 9g; Dogwood fruit 6g. Preparation method is with embodiment 1.
Unaccomplished matter among the present invention can be fully with reference to prior art, knowledge and production custom etc.
Following case derives from total case, and its total effective rate reaches 95%.
Case | Illness | Before taking medicine | After taking medicine |
Case 1: Zhao * * man, 27 years old, | Chronic active hepatitis B (jaundice type) | Urine is yellow, order is yellow, weak receive poor, the body nosebleed epistaxis of itching, diarrhea with loose stool, whole skin and icteric sclera, abdomen is soft, positive sign, wiry and frequent pulse, the thick greasy chemical examination of red tongue body tongue: ALT130, Tbi1416umol/L, B ultrasonic shows hepatosplenomegaly, the anti-HBC of HBsAg, HBeAg is all positive. | Liver function is chemically examined all normally after taking medicine 6 months, transference cure, and liver and spleen retraction, HBeAg turns out cloudy, and cures. |
Case 2: Zheng * * woman, 43 years old, | Chronic active hepatitis B | The apocleisis of feeling sick, weak, the poor dreaminess of sleeping, just do yellow, uncomfortable liver area, through chemical examination ALT value 1103.4u, great three positive, B ultrasonic show that liver fills the air impairedly, spleen is slightly large. Body is become thin, and belly is flat soft, the liver spleen do not lay one's hand on and, sclera is without xanthochromia, arteries and veins flood and string, red tongue body is without tongue. | Through taking medicine 20, sx↓, ALT value 208.3u, the symptom on the 40th of taking medicine disappears substantially, ALT value 36.6u, liver function is stable after five months, and all disease disappearance spleens just bounce back, and HBeAg turns out cloudy. |
Case 3: Pei * *, man, 52 years old | Cirrhosis, splenomegaly 2CM | Sensation hepatic region pain, abdominal distension, nauseating, insomnia and dreamful sleep, B ultrasonic indication cirrhosis, splenomegaly 2CM, the liver function laboratory indexes is mostly normal, | After taking medicine 6 months, subjective symptoms disappears, and B ultrasonic indication liver spleen no abnormality seen follows up a case by regular visits to 3 every year normally |
Case 4: king * * man, 54 years old, | Cirrhotic ascites | The abdominal distension oliguria, edema of lower extremity, the gallbladder wall oedema was once used multiple diuretics, keep treatment such as antisterone, abdominal distension is alleviated for the moment, and aggravation has hunger gradually, dare not diet, the just dried Huang of urinating, floating pulse is and unable, and red tongue body is without tongue, chemical examination: liver function ALT84.4, AST55.4, TBil67, total protein TP63, A28, G35, A/G is inverted, B ultrasonic shows cirrhosis, moderate ascites, splenomegaly. | Ascites disappears after taking medicine five months, has rosy cheeks, and diet increases, and edema disappears, rear continue to take consolidated in three months, the liver function indices is tending towards normally curing |
Claims (9)
1. Chinese medicine for the treatment of hepatopathy is characterized in that it is made by components by weight mixture ratio:
The Radix Astragali 15~25g oriental wormwood 8~20g Radix Angelicae Sinensis 10~15g Radix Codonopsis 10~18g
Ligusticum wallichii 10~18g golden cypress 10~15g matrimony vine 5~10g fruit of Chinese magnoliavine 6~10g
The fruit of glossy privet 6~10g gekko 3~8g cassia bark 3~8g root of herbaceous peony 3~8g
Rhizoma cyperi 3~8g antelope's horn 1.5~4g
2. the Chinese medicine for the treatment of hepatopathy according to claim 1 is characterized in that the optimum ratio scheme of component described in the described Chinese medicine is:
The Radix Astragali 20~22g oriental wormwood 12~15g Radix Angelicae Sinensis 12~15g Radix Codonopsis 12~15g
Ligusticum wallichii 12~15g golden cypress 12~15g matrimony vine 6~8g fruit of Chinese magnoliavine 7~8g
The fruit of glossy privet 7~8g gekko 3~5g cassia bark 3~5g root of herbaceous peony 3~5g
Rhizoma cyperi 3~5g antelope's horn 2~2.5g
3. the Chinese medicine for the treatment of hepatopathy according to claim 1 and 2 is characterized in that described traditional Chinese medicinal components can also add the capsule of weeping forsythia 5~10g and Pogostemon cablin 5~10g.
4. the Chinese medicine for the treatment of hepatopathy according to claim 1 and 2 is characterized in that described traditional Chinese medicinal components can also add the dried rhizome of rehmannia 10~15g and donkey-hide gelatin 6~9g.
5. a kind of Chinese medicine for the treatment of hepatopathy according to claim 3 is characterized in that described traditional Chinese medicinal components can also add the dried rhizome of rehmannia 10~15g and donkey-hide gelatin 6~9g.
6. a kind of Chinese medicine for the treatment of hepatopathy according to claim 1 and 2 is characterized in that described traditional Chinese medicinal components can also add RADIX ACONITILATERALIS PREPARATA 6~9g and dogwood fruit 6~9g.
7. the Chinese medicine for the treatment of hepatopathy according to claim 3 is characterized in that described traditional Chinese medicinal components can also add RADIX ACONITILATERALIS PREPARATA 6~9g and dogwood fruit 6~9g.
8. the Chinese medicine for the treatment of hepatopathy according to claim 4 is characterized in that described traditional Chinese medicinal components can also add RADIX ACONITILATERALIS PREPARATA 6~9g and dogwood fruit 6~9g.
9. the Chinese medicine for the treatment of hepatopathy according to claim 1 is characterized in that its manufacturing process is: be processed into pulvis behind the traditional Chinese medicine drying with above-mentioned prescription, become fine powder through regrind again, last honey is smelt ball.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021603367A CN1241613C (en) | 2002-12-26 | 2002-12-26 | Chinese medicine for treating hepatopathy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021603367A CN1241613C (en) | 2002-12-26 | 2002-12-26 | Chinese medicine for treating hepatopathy |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1509754A true CN1509754A (en) | 2004-07-07 |
CN1241613C CN1241613C (en) | 2006-02-15 |
Family
ID=34237843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021603367A Expired - Fee Related CN1241613C (en) | 2002-12-26 | 2002-12-26 | Chinese medicine for treating hepatopathy |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1241613C (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101829274B (en) * | 2010-05-13 | 2011-12-07 | 西双版纳傣族自治州民族医药研究所 | Medicament for treating liver disease |
CN101991810B (en) * | 2009-08-25 | 2012-02-08 | 王荣春 | Medicament for treating hepatitis A and hepatitis B |
CN104288332A (en) * | 2014-10-27 | 2015-01-21 | 哈尔滨金玉科技开发有限公司 | Traditional Chinese medicine for treating quick weight loss fatty liver and preparation method thereof |
-
2002
- 2002-12-26 CN CNB021603367A patent/CN1241613C/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101991810B (en) * | 2009-08-25 | 2012-02-08 | 王荣春 | Medicament for treating hepatitis A and hepatitis B |
CN101829274B (en) * | 2010-05-13 | 2011-12-07 | 西双版纳傣族自治州民族医药研究所 | Medicament for treating liver disease |
CN104288332A (en) * | 2014-10-27 | 2015-01-21 | 哈尔滨金玉科技开发有限公司 | Traditional Chinese medicine for treating quick weight loss fatty liver and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1241613C (en) | 2006-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1317026C (en) | Traditional Chinese medicine prepn. for treating lithiasis and its prepn. method | |
CN1081067C (en) | Chinese medicine prescription for curing hepatitis, cholangitis, pancreatitis and cirrhosis | |
CN1562160A (en) | Composite medicine for treating hepatitis B complication | |
CN1692939A (en) | Traditional Chinese medicine pill for treating hepatitis B, and its prepn. method | |
CN1720965A (en) | Chinese medicinal composition for treating acute icterohepatitis | |
CN1241613C (en) | Chinese medicine for treating hepatopathy | |
CN103142920A (en) | Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof | |
CN1063954C (en) | Chinese patent medicine-powder preparation for curing hepatitis B | |
CN1060938C (en) | Chinese medicinal instant powder for treatment of B-hepatitis | |
CN101618172B (en) | Traditional Chinese medicine for treating hepatitis B, cirrhosis, liver cancer and liver ascites | |
CN114699498A (en) | Pharmaceutical composition for resisting chronic hepatitis B and application thereof | |
CN1939498A (en) | Chinese-medicinal preparation for treating psoriasis | |
CN1879783A (en) | A medicine for treating diabetes | |
CN1070378C (en) | Medicine for curing hepatitis B | |
CN1319587C (en) | Medicine powder for liver and spleen diseases | |
CN1176123A (en) | Medicine for chronic hepatitis B and its preparation | |
CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
CN110575521A (en) | Traditional Chinese medicine composition for treating chronic hepatitis B and hepatitis B-related compensatory cirrhosis and application | |
CN103520429A (en) | Traditional Chinese medicinal preparation used for treating rheumatic loin and leg pains | |
CN113713068B (en) | Foot bath powder capable of tonifying spleen, eliminating dampness, promoting blood circulation and soothing nerves | |
CN1286483C (en) | Chinese traditional drug pills capable of protecting liver, resisting hepatic fibrosis and expelling toxins | |
CN103656277B (en) | The medicine for the treatment of hepatic ascites | |
CN102614420A (en) | Chinese medicine preparation for curing atrophic glossitis | |
CN105362966A (en) | Method for preparing traditional Chinese medicine preparation for treating fatty liver | |
CN1106856C (en) | Hepatosis treating medicine and its preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |